Machine Learning with Alpha Toxin Phenotype to Predict Clinical Outcome in Patients with Staphylococcus aureus Bloodstream Infection
نویسندگان
چکیده
Staphylococcus aureus bloodstream (SAB) infection remains a leading cause of sepsis-related mortality. Yet, current treatment does not account for variable virulence traits that mediate host dysregulated immune response, such as SA α-toxin (Hla)-mediated thrombocytopenia. Here, we applied machine learning (ML) to bacterial growth images combined with platelet count data predict patient outcomes. We profiled Hla phenotypes isolates collected from patients bacteremia by taking smartphone beta-hemolytic on sheep blood agar (SBA). Electronic medical records were reviewed extract relevant laboratory and clinical data. A convolutional neural network was process the plate image input along day 1 generate ML-based models thrombocytopenia 4 total 229 infected strains exhibiting varying zone sizes beta-hemolysis SBA included. 539 generated inputs model development. One-third developed at onset, an overall mortality rate 18.8%. The ML algorithm showed strong performance (AUC 0.92) predicting modest 0.711) Our findings support further development validation proof-of-concept application in digital microbiology, measure factor production carries prognostic significance can help guide selection.
منابع مشابه
Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection.
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) infections varies in the literature, a problem complicated by the lack of routine screening procedures; however, limited data suggest that hVISA has been associated with persistent bloodstream infections (BSI) and vancomycin failure, yet these studies have been confounded by design issues. We conducted this st...
متن کاملStaphylococcus Aureus Carriage in Patients with Psoriasis
Background: The aggravating role of Staphylococcus aureus is well known in atopic dermatitis but has not yet been proven in psoriasis. The role of Staphylococcus aureus superantigens is emphasized in the initiation, maintenance and complications of psoriasis. We investigated the frequency of nasal, axillary, and perineal carriage of Staphylococcus aureus (SA) in patients with psoriasis and its ...
متن کاملTime to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.
Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in bloodstream infections (BSIs). The purpose of this study was to evaluate the time to positivity (TTP) of blood cultures in patients with Staphylococcus aureus BSIs and to assess its impact on clinical outcome. We performed a historical cohort study with 91 adult patients with S. aureus BSIs. TTP...
متن کاملMethicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.
INTRODUCTION Methicillin-resistant Staphylococcus aureus (MRSA) is spread out in hospitals across different regions of the world and is regarded as the major agent of nosocomial infections, causing infections such as skin and soft tissue pneumonia and sepsis. The aim of this study was to identify risk factors for methicillin-resistance in Staphylococcus aureus bloodstream infection (BSI) and th...
متن کاملPermeabilization of rat hepatocytes with Staphylococcus aureus alpha- toxin
Pathogenic staphylococci secrete a number of exotoxins, including alpha-toxin. alpha-Toxin induces lysis of erythrocytes and liposomes when its 3S protein monomers associate with the lipid bilayer and form a hexomeric transmembrane channel 3 nm in diameter. We have used alpha-toxin to render rat hepatocytes 93-100% permeable to trypan blue with a lactate dehydrogenase leakage less than or equal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Toxins
سال: 2023
ISSN: ['2072-6651']
DOI: https://doi.org/10.3390/toxins15070417